Eric Wang quits as Ecofibre CEO by Steve Jones November 28, 2023November 28, 2023 Ecofibre has announced the departure of managing director and chief executive Eric Wang after seven years […]
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023October 3, 2023
Second trial flagged by Ecofibre in bid to get S3 product over the line by Steve Jones February 1, 2023February 1, 2023
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022November 2, 2022
Ecofibre launches low-cost CBD product and pins hope on OTC market to drive profitability by Steve Jones August 23, 2022August 23, 2022
Over-the-counter sales to create ‘most significant opportunity in years’ says Ecofibre boss by Steve Jones August 3, 2022August 5, 2022
Ecofibre; LGP; Creso Pharma; Rua Bioscience; The Pain Clinic; MGC Pharma by Martin Lane July 28, 2022August 1, 2022
Ecofibre CEO Eric Wang: ‘we’re through the worst, now it’s my job to deliver’ by Steve Jones July 21, 2022August 5, 2022